Futura Medical
A year of delivery, with key milestones achievedFutura Medical
Raising £12m through £10m placing and £2m retail offerFutura Medical
MED3000 receives CE Mark as a Class II(b) deviceFutura Medical
FY21 is set to be a year of executionFutura Medical
EU Notified Body recommends MED3000 approvalFutura Medical
Commercialisation deal for China and SE AsiaFutura Medical
MED3000: FDA details the scope of confirmatory studyFutura Medical
MED3000 on course for OTC approval in Europe and USFutura Medical
FDA green lights MED3000 for OTC approvalFutura Medical
AGM statement confirms MED3000 filings on track